Thus, ectopic overexpression of TP53INP2 sensitized cancer cells to DR ligands-induced apoptosis [7], suggesting modulation of TP53INP2 proteostasis as a new strategy to improve the apoptosis induced by DR ligands. The gene discussed is TP53INP2; the disease is cancer.